[Safety in the use of ultrasound in rheumatology during the COVID-19 Pandemic. Spanish Society of Rheumatology positioning paper] [0.03%]
[新冠肺炎疫情期间风湿病超声检查的安全性问题西班牙风湿病学会立场文件]
Lucía Mayordomo,Juan Molina Collada,Félix M Francisco Hernández et al.
Lucía Mayordomo et al.
Ultrasound is a widely implemented imaging modality in rheumatology practice that implies a great interaction between patient and professional. The COVID-19 pandemic requires a change in our clinical practice, through the adoption of new st...
[Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19] [0.03%]
安卡拉用于治疗COVID-19引起的急性呼吸窘迫的建议提案
Alejandro Muñoz-Jiménez,Esteban Rubio-Romero,José Luis Marenco de la Fuente
Alejandro Muñoz-Jiménez
The outcome of the SARS-CoV-2 (COVID-19) infection fundamentally affects the lung field, causing acute respiratory distress syndrome (ARDS). This process is an inflammatory picture, involving an NLRP3 inflamosome-triggered cytokine storm, t...
Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients [0.03%]
秋水仙碱：潜在的治疗COVID-19药物。5例患者的经验报告
Giovanni Montealegre-Gómez,Edgar Garavito,Arley Gómez-López et al.
Giovanni Montealegre-Gómez et al.
COVID-19 is a newly emerged disease that has become a global public health challenge. Due to a lack of knowledge about the virus, a significant number of potential targets for using a particular drug have been proposed. Five cases with a cl...
[Therapeutic Options for the Management of Severe COVID-19: A Rheumatology Perspective] [0.03%]
[风湿病学视角下的重症新冠肺炎治疗选项]
Claudia Mendoza-Pinto,Mario García-Carrasco,Pamela Munguía Realpozo et al.
Claudia Mendoza-Pinto et al.
The novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). Acute respiratory distress syndrome, multiorgan dysfunction and thrombotic events are among the leading causes of dea...
[Comparison of the first and sixth waves of the SARS-COV-2 coronavirus pandemic in patients with immune-mediated disease] [0.03%]
自身免疫病患者中第六波与第一波SARS-COV-2冠状病毒感染的比较分析
C Lobo-Rodriguez,A M López-Calleja,P Morales de Los Ríos et al.
C Lobo-Rodriguez et al.
Recent evidence shows that COVID-19 infection does not have a worse prognosis in patients with immune-mediated inflammatory diseases (IMID), although they develop a worse response to vaccination.Objective To compare the incidence of COVID-1...
[ANALYSIS OF FACTORS INVOLVED IN THE DEVELOPMENT OF HUMORAL RESPONSE TO VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH RHEUMATIC PATHOLOGY UNDER BIOLOGICAL TREATMENT] [0.03%]
风湿病患者接受生物制剂治疗后接种新冠疫苗产生抗体的影响因素分析
E Flores-Fernández,I Vázquez-Gomez,E Valls-Pascual et al.
E Flores-Fernández et al.
Background and objective: In the context of the SARS-CoV-2 pandemic, the development of new vaccines and their efficacy in patients with immune-mediated rheumatic diseases has been a target to investigate. The objective o...
Case Reports
Reumatologia clinica. 2023 Jun 6. DOI:10.1016/j.reuma.2023.05.005 2023
Miguel Sogbe,Andrés Blanco-Di Matteo,I Madeleine Di Frisco et al.
Miguel Sogbe et al.
Introduction: Cases of acute myocarditis have been after administration of the BNT162b2 and Ad26.COV2.S vaccine. Objective: Describe an...
Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients [0.03%]
新冠肺炎后的间质性肺疾病：风湿关节炎患者面临的新治疗挑战
Jose Luis Morell-Hita,Juan A Rigual-Bobillo,Cristina C Macía-Villa
Jose Luis Morell-Hita